Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
CSL Seqirus is seeking a portfolio-level regulatory strategist to set regional strategy across APAC, LATAM, MEA, CIS, Adriatics and Partner Regions. Based in Maidenhead with a hybrid setup, you will work 3 days on-site to align with global strategy and regional requirements.
You’ll influence life-cycle management and health authority interactions beyond single approvals. You will collaborate with LRR, RPR and cross-functional teams to ensure timely, compliant submissions and practical pathway
This a portfolio-level regulatory strategy role covering regions with diverse regulatory requirements and market dynamics: APAC, LATAM, MEA, CIS, Adriatics and Partner Business Regions. Working with the Therapeutic Area Lead, you'll set regional regulatory strategy for a defined product portfolio - not just chasing individual approvals, but shaping the pathway decisions, life cycle management, and health authority relationships that determine how well global strategy actually lands on the ground.
Location: Maidenhead/Hybrid, 3-days a week on-site
A global regulatory strategy depends on strong regional insights across all markets. These regions do not follow the same dynamics as the US or EU - different evidentiary bars, different timelines, different risk calculus - and getting that wrong costs approval time and access. This role owns that judgment: turning global strategy into regionally credible submissions and pushing regional intelligence back up into global thinking before it becomes a problem rather than after.
You’ll act as the regional regulatory strategist for your product portfolio, balancing scientific rigor with the practical realities of dozens of different regulatory systems, while building the relationships - internal and external - that make timely approval possible.
CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world. To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
CSL is an Equal Opportunity Employer.
If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
Watch our 'On the Front Line' video to learn more about CSL Seqirus.
If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please click here.
CSL Global Privacy Notice for Job Applicants and Candidates.